NL-OMON50161已完成不适用
SARS-CoV-2 immune response in asymptomatic patients - SCOUT-2 study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Adult (age * 18 years)
- •- Screened for COVID-19 according to the national guidelines because of a
- •planned surgical or interventional procedure under general anesthesia.
- •- Tested positive for SARS-CoV-2 with RT-PCR.
- •- Asymptomatic at the moment of screening: no suspicion for COVID-19 for at
- •least 48 hours prior to screening, based on a standardized questionnaire
- •containing the following complaints: cough, dyspnoea, fever, general malaise,
- •myalgia, headache, extreme fatigue (new onset), throat ache, obstructed/runny
- •nose, loss of smell, loss of taste, abdominal pain, diarrhoea and vomiting.
排除标准
- •Not able or willing to give informed consent
研究者
相似试验
招募中
不适用
SARS-CoV-2 immune response in asymptomatic patientsNL-OMON24645Amsterdam UMC, location AMC75
已完成
不适用
SARS-CoV-2 serology by mild symptoms of diseaseSARS-CoV-2 infection10047438NL-OMON50020Medlon b.v. Medische Diagnostiek39
进行中（未招募）
1 期
Response to corona vaccination in patients with primary Sjögren's syndromePrimary Sjögren's syndromeEUCTR2021-001414-10-NLniversity Medical Center Groningen180
已完成
4 期
Vaccine response against SARS-CoV-2 in patients with primary Sjögren*s syndrome1000381610047438Sjögren's syndromeNL-OMON51179niversitair Medisch Centrum Groningen180
进行中（未招募）
1 期
SARS-CoV-2 immune responseimmune response to COVDI-19 vaccinationEUCTR2021-001202-30-NLDiakonessenhuis400